Brussels, Belgium | | Investor Type | VC Firm |
| Type of Fund | Venture Capital Fund |
| Industries | BioTech • Hardware (& Manufacturing) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Oncology • Consumer • Pharmaceutical (& Medicine) • Industrials |
| Stages | MBO/LBO, Acquisition, Early Stage VC, Seed, Series A, Series B |
| Investing | Germany • Japan • France • Italy • Switzerland • Netherlands • Denmark • Belgium • Finland • Norway |
| Assets Under Management | $100,000,000 |
What is Newton Biocapital?
Newton Biocapital is a venture capital fund deeply rooted in the biotech and life science sectors, gearing its financial instruments towards the growth and evolution of these industries. With assets under management of around 100 million, they exhibit significant involvement in financing innovative biotech and life science projects in Europe and Japan.
Founded in 2017 with a headquarters in Frankfurt am Main, Germany, Newton Biocapital operates on the prowess of equity and debt to support early-stage ventures, management buyouts/leveraged buyouts, and acquisitions. The fund operates with a specific focus towards chronic health conditions, aiming to alleviate patient and societal burdens through its investment strategy.
Their specialty stretches into the spheres of chronic health issues, where identifying and nurturing promising solutions becomes their mission. In doing so, they leverage scientific and medical expertise alongside their network to pinpoint and pursue the most promising investment opportunities across Europe and Japan. Newton Biocapital is actively involved in their portfolio companies, engaging as board members and providing guidance in preclinical and clinical program selections across a variety of technologies and disease areas.
The fund prides itself on its strong ties to the life sciences ecosystems in both regions, facilitating synergy and creating mutually beneficial relationships that pave the way to optimal exits for their investments. Their focus industries include Biotech, Hardware, Medical Devices, Healthcare, Life Science, Oncology, Consumer, Pharmaceutical, and Industrials.
By opening doors through connections with local and international investors as well as pharma, they ensure that their portfolio companies are well-positioned to achieve significant developmental milestones and business growth.
What they say:
We are an investment fund committed to supporting innovations within the industry.
What we look for: We invest in life sciences ventures, particularly those focused on chronic diseases.
What are the investment firms similar to Newton Biocapital
Fischer Investment Capital
Whiz Partners Inc.
D2E Capital NV
Fund+
Noshaq
Semble Ventures
Capricorn Partners
Supply Chain Equity Partners
EB Capital
Vanedge Capital
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 71-75 Shelton Street, Covent Garden, WC2H 9JQ
- London, U.K.
- contact@angelspartners.com
